Primary Pulmonary Malignant Fibrous Histiocytoma
PDF
Cite
Share
Request
Case report
VOLUME: 18 ISSUE: 2
P: 54 - 56
April 2017

Primary Pulmonary Malignant Fibrous Histiocytoma

Turk Thorac J 2017;18(2):54-56
1. Department of Thoracic Surgery, Acıbadem University Atakent Hospital, İstanbul, Turkey
2. Clinic of Chest Diseases, Haydarpaşa Training Hospital, İstanbul, Turkey
3. Department of Thoracic Surgery, Süreyyapaşa Chest Diseases and Thoracic Surgery Training Hospital, İstanbul, Turkey
4. Clinic of Pathology, Süreyyapaşa Chest Diseases and Thoracic Surgery Training Hospital, İstanbul, Turkey
No information available.
No information available
Accepted Date: 18.07.2019
Online Date: 18.07.2019
Publish Date: 18.07.2019
PDF
Cite
Share
Request

Abstract

Abstract

Malignant fibrous histiocytoma (MFH) cases are classified within the group of nonclassified sarcomas. The etiopathogenesis is unclear; however, MFH commonly develops in scar tissue and in areas exposed to radiation. MFH is the most common soft tissue sarcoma in adults and may be borne in the lungs, chest wall, mediastinum, or other tissues. Primary MFH of the lung constitutes less than 0.2% of all pulmonary neoplasms; thus, an optimal treatment strategy has not yet been elucidated. We aimed to report a case of MFH of the lung with subsequent treatment administration.

Keywords:
Malignant fibrous histiocytoma, pulmonary neoplasm, lung